circRNA-SFMBT2 orchestrates ERα activation to drive tamoxifen resistance in breast cancer cells

Dysregulated ERα signaling is responsible for endocrine resistance and eventual relapse in patients with estrogen receptor-positive (ER(+)) breast cancer. Thus, identifying novel ERα regulators is necessary to fully understand the mechanisms of endocrine resistance. Here, we identified circRNA-SFMBT...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Zheng, Li, Yaming, Han, Dianwen, Wang, Xiaolong, Li, Chen, Chen, Tong, Li, Wenhao, Liang, Yiran, Luo, Dan, Chen, Bing, Wang, Lijuan, Zhao, Wenjing, Yang, Qifeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10390580/
https://www.ncbi.nlm.nih.gov/pubmed/37524698
http://dx.doi.org/10.1038/s41419-023-06006-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10390580/
https://www.ncbi.nlm.nih.gov/pubmed/37524698
http://dx.doi.org/10.1038/s41419-023-06006-5

Ejemplares similares